CA2199609A1 - Recepteurs de type 3 de l'interleukine 1 - Google Patents

Recepteurs de type 3 de l'interleukine 1

Info

Publication number
CA2199609A1
CA2199609A1 CA002199609A CA2199609A CA2199609A1 CA 2199609 A1 CA2199609 A1 CA 2199609A1 CA 002199609 A CA002199609 A CA 002199609A CA 2199609 A CA2199609 A CA 2199609A CA 2199609 A1 CA2199609 A1 CA 2199609A1
Authority
CA
Canada
Prior art keywords
type
receptor
sequence
nucleic acid
interleukin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002199609A
Other languages
English (en)
Inventor
Errol B. Desouza
William Clevenger
Tilman Oltersdorf
Timothy W. Lovenberg
Chen W. Liaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurocrine Biosciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2199609A1 publication Critical patent/CA2199609A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002199609A 1994-09-09 1995-09-11 Recepteurs de type 3 de l'interleukine 1 Abandoned CA2199609A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30395794A 1994-09-09 1994-09-09
US08/303,957 1994-09-09

Publications (1)

Publication Number Publication Date
CA2199609A1 true CA2199609A1 (fr) 1996-03-14

Family

ID=23174426

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002199609A Abandoned CA2199609A1 (fr) 1994-09-09 1995-09-11 Recepteurs de type 3 de l'interleukine 1

Country Status (5)

Country Link
EP (1) EP0779923A2 (fr)
JP (1) JPH10508743A (fr)
AU (1) AU705595B2 (fr)
CA (1) CA2199609A1 (fr)
WO (1) WO1996007739A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846782A (en) 1995-11-28 1998-12-08 Genvec, Inc. Targeting adenovirus with use of constrained peptide motifs
US6465253B1 (en) 1994-09-08 2002-10-15 Genvec, Inc. Vectors and methods for gene transfer to cells
US5770442A (en) * 1995-02-21 1998-06-23 Cornell Research Foundation, Inc. Chimeric adenoviral fiber protein and methods of using same
US6127525A (en) * 1995-02-21 2000-10-03 Cornell Research Foundation, Inc. Chimeric adenoviral coat protein and methods of using same
US6783980B2 (en) 1995-06-15 2004-08-31 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
US6326472B1 (en) 1997-10-15 2001-12-04 Schering Corporation Human receptor proteins; related reagents and methods
EP1029043A1 (fr) * 1997-10-15 2000-08-23 Schering Corporation Proteines receptrices humaines et reactifs et methodes associes
US20030017138A1 (en) 1998-07-08 2003-01-23 Menzo Havenga Chimeric adenoviruses
US6929946B1 (en) 1998-11-20 2005-08-16 Crucell Holland B.V. Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
US6913922B1 (en) 1999-05-18 2005-07-05 Crucell Holland B.V. Serotype of adenovirus and uses thereof
US6492169B1 (en) 1999-05-18 2002-12-10 Crucell Holland, B.V. Complementing cell lines
WO2003104467A1 (fr) 2002-04-25 2003-12-18 Crucell Holland B.V. Moyens et procede de production de vecteurs d'adenovirus
FR2804028B1 (fr) * 2000-01-21 2004-06-04 Merial Sas Vaccins adn ameliores pour animaux de rente
US6843987B2 (en) 2000-02-02 2005-01-18 Schering Corporation Mammalian cytokines; receptors; related reagents and methods
DE60138403D1 (de) 2000-09-26 2009-05-28 Crucell Holland Bv Adenovirale vektoren für die übertragung von genen in zellen der skelettmuskulatur oder myoblasten
AU2019306217B2 (en) 2018-07-16 2024-01-25 Regeneron Pharmaceuticals, Inc. Anti-IL36R antibodies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968607A (en) * 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
ATE242322T1 (de) * 1992-03-30 2003-06-15 Immunex Corp Fusionsprotein , das zwei rezeptoren des tumornekrose-faktors enthält
CA2157782A1 (fr) * 1993-03-08 1994-09-15 Joseph C. Glorioso Transfert de gene pour le traitement d'un tissu conjonctif chez un mammifere hote

Also Published As

Publication number Publication date
AU705595B2 (en) 1999-05-27
AU3680595A (en) 1996-03-27
EP0779923A2 (fr) 1997-06-25
JPH10508743A (ja) 1998-09-02
WO1996007739A3 (fr) 1996-04-18
WO1996007739A2 (fr) 1996-03-14

Similar Documents

Publication Publication Date Title
FI106044B (fi) Menetelmä nisäkkään interleukiini-4-reseptorin (IL-4R) ja sen vasta-aineen tuottamiseksi ja IL-4R:ä koodaava DNA, vektori ja isäntäsolu
EP0318296B1 (fr) L'ADN codant des proteines lieés au IL-1 humain
CA2199609A1 (fr) Recepteurs de type 3 de l'interleukine 1
EP0658200B1 (fr) Recepteurs de glucagon
CA2147372C (fr) Gene de polypharmacoresistance
JP2002515246A (ja) Ｉｌ−１７相同的ポリペプチドとその治療用途
CZ2000490A3 (cs) Interleukin-18-vazebné proteiny, příprava a použití
IE66494B1 (en) Granulocyte-colony stimulating factor receptors
EP0724637B2 (fr) Recepteurs du facteur 2 liberant la corticotropine
EP1514932A2 (fr) Récepteurs de glucagon
US5786203A (en) Isolated nucleic acid encoding corticotropin-releasing factor2 receptors
US20060079668A1 (en) Junctional adhesion molecule splice variants
CA2490051A1 (fr) Nouvelles sequences gdf-9 et gdf-9b (bmp-15) destinees a modifier la fonction ovarienne et la vitesse d'ovulation chez des mammiferes
US6239268B1 (en) Interleukin-1 type 3 receptors
JP3067798B2 (ja) 顆粒球コロニー刺激因子レセプター
US20040101528A1 (en) Type I IL-1 receptors
EP0860501A2 (fr) Récepteurs du facteur 2 libérant la corticotropine
AU671160C (en) Multidrug resistance gene
CA2448557A1 (fr) Gene de polypharmacoresistance
MXPA98003883A (en) Chemiocine from pancreas de melitus de diabetes that does not depend on insul

Legal Events

Date Code Title Description
FZDE Dead